Story perspectives
Myomo Sees 162% Revenue Surge, Eyes $53M Goal
6/7/2025
23 3
1 of 1
Story summary
- Myomo Inc., located in Burlington, Massachusetts, specializes in neurorehabilitation for upper-limb paralysis.
- The MyoPro device is the sole FDA-cleared non-invasive myoelectric orthosis, aiding users in regaining arm and hand function.
- Q1 2025 revenue hit $9.8 million, reflecting a 162% year-over-year increase due to a growing patient base.
- Myomo targets $50-$53 million in annual revenue and aims for positive cash flow by Q4 2025.
